Maxim Group lowered its price target on Gilead Sciences (NASDAQ: GILD) to $89.00 (from $94.00) while maintaining a Buy rating.

Analyst PT Change

Gilead Sciences (GILD) PT Lowered to $90 at RBC CapitalMay 2, 2018 8:26 AM Gilead Sciences (GILD) PT Lowered to $79 at BairdMay 2, 2018 7:51 AM Gilead Sciences (GILD) PT Lowered to $81 at Morgan StanleyMay 2, 2018 7:45 AM Gilead Sciences (GILD) PT Lowered to $85 at CowenMay 2, 2018 6:31 AM Gilead Sciences (GILD) PT Lowered to $72 at Leerink PartnersMay 2, 2018 6:23 AM Gilead Sciences (GILD) PT Lowered to $90 at BarclaysMay 2, 2018 3:54 AM